Chicago, IL, United States of America

Hunter Lane

USPTO Granted Patents = 6 

Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 106(Granted Patents)


Company Filing History:


Years Active: 2019-2024

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Hunter Lane: Innovator in Cancer Research Technologies

Introduction

Hunter Lane is a prominent inventor based in Chicago, IL (US), known for his significant contributions to cancer research and treatment technologies. With a total of 6 patents, Lane has developed innovative methods and systems that enhance the understanding and treatment of cancer.

Latest Patents

Among his latest patents, Lane has created a method and system for data-based cancer research and treatment. This system involves storing user application programs that require specific data subsets to generate genomic variant characterizations for patients with cancerous cells. The method includes obtaining clinical records data, generating genomic sequencing data for both cancerous and normal cells, and structuring this data for efficient storage and retrieval. Another notable patent focuses on a system for managing user application programs and micro-service programs for multiple patients undergoing cancer treatment. This system optimizes the storage and retrieval of clinical records and sequencing data, ensuring that the necessary information is readily available for application interfacing.

Career Highlights

Hunter Lane has worked with notable companies in the field, including Tempus Labs, Inc. and Tempus AI, Inc. His experience in these organizations has allowed him to collaborate on cutting-edge projects aimed at improving cancer treatment methodologies.

Collaborations

Lane has had the opportunity to work alongside esteemed colleagues such as Eric Lefkofsky and Michael Lucas, further enhancing his expertise and contributions to the field of cancer research.

Conclusion

Hunter Lane's innovative work in cancer research technologies exemplifies the impact of data-driven approaches in medical science. His patents and collaborations reflect a commitment to advancing treatment options for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…